Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Willingsford
London, United Kingdomwillingsford.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Willingsford is a UK-based healthcare company that develops and manufactures advanced wound care and dermatological products. The company's core technology, SertaSil, consists of microporous particles that facilitate wound healing through a non-pharmacological, physical mechanism by removing exudate, bacteria, and toxins. Their product line includes SertaSil for chronic and acute wounds, AcuSil for skin conditions such as acne and rosacea, and specialized veterinary treatments. Willingsford's approach focuses on providing evidence-based, cost-effective solutions that reduce the need for antibiotics and improve patient outcomes. The company serves both the human healthcare and veterinary markets globally.
- Therapeutic areas
- EndocrinologyDermatologyInfectious Diseases
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Consumable Medical Devices
Beyond the preview
Go deeper on Willingsford.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Willingsford.